AMBRX BIOPHARMA INC shareholders Q3 2023

AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 51 filers reported holding AMBRX BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 1.5%.

AMBRX BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 6,793$78,1200.05%
BOOTHBAY FUND MANAGEMENT, LLC 99,100$1,139,6500.03%
Holocene Advisors, LP 486,562$5,595,4630.02%
HHLR ADVISORS, LTD. 31,735$364,9530.01%
FIRST MANHATTAN CO. LLC. 135,003$1,552,5340.01%
ALPS ADVISORS INC 45,531$523,6070.00%
MACQUARIE GROUP LTD 250,000$2,875,0000.00%
Cutler Group LLC / CA 2,800$320.00%
MILLENNIUM MANAGEMENT LLC 464,633$5,343,2800.00%
Cutler Group LLC / CA 9,100$210.00%
TD ASSET MANAGEMENT INC 110,456$1,270,2440.00%
FMR LLC 1,761,058$20,252,1670.00%
Citadel Advisors 768,825$8,841,4880.00%
Cutler Group LLC / CA 4,800$60.00%
Belvedere Trading LLC 29,500$339,2500.00%
Squarepoint Ops LLC 22,132$254,5180.00%
MILLENNIUM MANAGEMENT LLC 112,300$1,291,4500.00%
PRICE T ROWE ASSOCIATES INC /MD/ 821,564$9,4480.00%
GTS SECURITIES LLC 25,900$297,8500.00%
SIMPLEX TRADING, LLC 68,551$7880.00%
External links

This page lists AMBRX BIOPHARMA INC's shareholders in Q3 2023. To view AMBRX BIOPHARMA INC's shareholder history, click here.